Cofertility的动态

Today, the 21st of April, we celebrate International Creativity and Innovation Day. In the field of Reproductive Medicine and Infertility treatment, challenges once deemed insurmountable are now being overcome through the steady, thoughtful application of research, innovation, cutting-edge technology, and clinical practice. #InternationalCreativityAndInnovationDay #Innovation #Creativity #Technology #Research #Sustainability #ClinicalPractice #FutureIsNow #FertilityAndRenewal #InnovationsInReproductiveMedicine #ReproductiveMedicineinUAE #KazimsFertilityBarza #COP28?

As part of my presentation at the ASRM course this year in Denver, Colorado, discussing how to find surgical and non-surgical approaches to address fibroid treatment inequity. I highlighted many examples but this is a classic example of the agony some women in the Middle East suffer due to deep cultural beliefs about preserving virginity. Our patient, a well-educated lady from the Gulf area, fully sponsored by her government, suffered from multiple fibroids, one of which was 7 cm and deeply impacted in the vagina. She experienced severe anemia and took many medications, both hormonal and non-hormonal, for many years. Her BMI increased to 41. She and her family refused any procedure involving a vaginal approach. She traveled for multiple international consultations, but they consistently refused any open or vaginal technique. This case illustrates how cultural and religious beliefs can influence and affect a patient's quality of life. As medical professionals, we must find ways to respect their wishes while improvising to help them. I am not only honored that the American Society for Reproductive Medicine chose me as a pre-congress faculty member, but I also thank them for allowing me to express and spread an important message to all members interested in fibroid treatments. I encourage you to meet us at 5 pm next Monday during the group social hour so we can enroll many people across the globe to help more patients. Here is The link of the surgical video . https://lnkd.in/dn8-yV2S American Society for Reproductive Medicine - ASRM #fibroid #FSIG #treatment_inequity #fibroidawareness #GULF #vaginal_bleeding #ASRM2024

Check out our last commentary on the adenomyosis in IVF.

We sat down with Mina Alikani, Giles Palmer, Jacques Cohen, and Francesca Farlie from Alpha Scientists and the International IVF Initiative, lead authors and the organizing team behind recent paper ‘Sustainability in the IVF laboratory: recommendations of an expert panel’, to discuss the genesis of the project, the issues they are tackling and their recommendations for the future of green IVF. Their article is the first of its kind, making recommendations for more environmentally-conscious sustainable procedures in the IVF lab, resulted from an international panel of experts, enthusiasts and professionals in reproductive medicine, environmental science, architecture, biorepository, and law. The full interview with links to the article is available on our new YouTube channel https://lnkd.in/e8cRpXNS ? #RBMOinterviews #Sustainability #LabCulture #ClinicalEmbryology #ReproductionTechnologyandSociety #HealthcareSustainability #ClimateChange #CarbonFootprint #IvfLaboratoryWasteManagement #ReproductiveHealth #GreenCertification

Abstract submissions are now being accepted for the #IETS2025 Annual Conference, January 18 to 22, 2025, in Fort Worth, Texas. All accepted abstracts will be presented as posters and published in IETS' Reproduction, Fertility and Development journal. Abstracts are due by Tuesday, July 23, 2024, at 11:59 p.m. (CDT). For submission instructions visit https://ow.ly/ZRi550SBVfX. #EmbryoTechnology, #CallforAbstracts, #AnimalRepro, #EmbryoScience

Opinion: For psychedelic medicine, pursuing the highest quality evidence of safety and effectiveness must be the goal. The evidence-based path is always worth the work. https://trib.al/4OoGrDt

One of the areas we get involved in is research into new treatments and tests for pre-eclampsia and this paper out today - the Parrot 2 Trial is essential reading for clinicians and commissioners on the value of repeated PlGF testing. Marcus Green, CEO of Action on Pre-eclampsia, said: “These are really important findings showing that once the first test has been done, there is nothing to be gained from further testing. A single test can assure women with certainty if they are likely or unlikely to get pre-eclampsia.?We look forward to completion of roll-out of placental growth factor-based testing across England, with an urgent call for implementation in the devolved administrations across all four nations. These new results also provide a timely opportunity to tackle the higher burden of adverse outcomes due to pre-eclampsia in global settings.” Please share this widely. https://lnkd.in/eA4JmZsT

This new study from Raquel Del Gallego, Barbara Lawrenz, Baris Ata, Erkan Kalafat, Laura Melado Vidales, Ibrahim ElKhatib, and Human M. Fatemi,MD,PhD demonstrates the additive value of an almost forgotten and neglected ovarian reserve parameter in prognosticating unexpected poor or suboptimal response especially in women ≥35 years. In the era of individualized medicine, this finding can be utilized to appropriately counsel women undergoing ART and possibly decide to initiate a treatment based on the dynamics of basal FSH levels to ensure the harvest of the best possible number of oocytes. https://lnkd.in/eNQKPF2i ? #ClinicalAssistedReproductiveTechnology #BasalFsh #NormalFshRange #OocyteYield #OvarianReserve #PoseidonGroup2Patients

Really valuable bit of research - earlier work has demonstrated the utility of a predictive test for #preeclampsia (much cheaper and easier than doing placental blood flow analysis from ultrasound, too) - but doing more tests doesn't add further value. It is as important to know when and where #NHS tests do NOT offer benefits as when they do! It may not have the glamour of a 'shiny new thing' (test/product/intervention) but this is evidence that commissioners need...and from which patients and the public benefit.

Want to know more about our risk-mitigating, cryogenic transport solutions specific to the IVF industry? Follow our new Cryoport Systems' Reproductive Medicine Showcase Page for the latest updates, insights, and innovations when it comes to transporting reproductive materials. #ReproductiveMedicine #CryoportSystems